MMP10 and dysplasia: In our study we tried to assess the potential of MMP-3, MMP-7, MMP-10, and MMP-26, which showed significant differences in concentrations between the groups of healthy women, dysplasia patients, and cancer patients, and also demonstrated the ability to distinguish benign from malignant lesions.